A REAL-LIFE EXPERIMENTAL PILOT PROJECT OF BLOOD GLUCOSE MONITORING IN ARCTIC WINTER CONDITIONS
Background/Aims: Both self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM) are integral components of effective diabetes therapy and have an important role in assessing the safety of treatment. Integrating daily BG monitoring into diabetes management can be a useful tool f...
| Format: | Other/Unknown Material |
|---|---|
| Language: | English |
| Published: |
Morressier
2017
|
| Subjects: | |
| Online Access: | https://doi.org/10.26226/morressier.5c3c8157e668b9000b9f8ca6 https://openresearchlibrary.org/ext/api/media/8401fcd1-daaf-436b-84ae-14a56de29588/assets/external_content.pdf https://openresearchlibrary.org/viewer/8401fcd1-daaf-436b-84ae-14a56de29588 |
| Summary: | Background/Aims: Both self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM) are integral components of effective diabetes therapy and have an important role in assessing the safety of treatment. Integrating daily BG monitoring into diabetes management can be a useful tool for guiding various outdoor activities and preventing hypoglycemia. Aim was to verify whether SMBG/CGM systems would work reliably during outdoor expedition in polar winter conditions. Methods: A real-life experimental pilot project of BG monitoring in arctic winter conditions took place in the north of Finland above the polar circle in March 2018. An educated non-diabetic volunteer (diabetologist) performed week SMBG and CGM during polar back-country skiing expedition in wilderness. The devices tested were ContourTM Plus Oneu00ae for SMBG and Paradigm Veou00ae with Enliteu00ae sensor for CGM. Due to unavailability of electricity it was necessary to carry the batteries. Daily programme included approx. 12hrs of outdoor terrain skiing in continuous freezing and 12hrs of stay in simple wilderness huts.Results: CGM duration was 6days, 20hrs and 25min with a total of 1hr and 15min of missed data due to late calibration/weak signal. Average BG was 5.4u00b11.3mmol/L (3.6-8.2mmol/L) with average calibration BG readings 2.2 per day. 10% of readings were above target and 10% below target of 3.9-7.8mmol/L. Average sensor glucose was 5.0u00b10.8mmol/L. A total of 5 BG calibration alarm reminders were recorded.Conclusion: The real-life experimental project demonstrated practical utility and reliability of both SMBG and CGM systems in polar winter conditions. The project was not supported by any pharmaceutical company. |
|---|